[HTML][HTML] Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
Q Hao, M Tampi, M O'Donnell, F Foroutan… - Bmj, 2018 - bmj.com
Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
[HTML][HTML] Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
Q Hao, M Tampi, M O'Donnell, F Foroutan… - BMJ, 2018 - bmj.com
Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
Q Hao, M Tampi, M O'Donnell… - BMJ (Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
Q Hao, M Tampi, M O'Donnell… - BMJ: British Medical …, 2018 - search.proquest.com
Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack
Q Hao, M Tampi, M O'Donnell, F Foroutan… - BMJ: British Medical …, 2018 - JSTOR
OBJECTIVE To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
[HTML][HTML] Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
Q Hao, M Tampi, M O'Donnell, F Foroutan… - The BMJ, 2018 - ncbi.nlm.nih.gov
Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Q Hao, M Tampi, M O'Donnell, F Foroutan… - … (Clinical Research ed …, 2018 - europepmc.org
Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Q Hao, M Tampi, M O'Donnell, F Foroutan… - … (Clinical Research ed …, 2018 - europepmc.org
Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …